FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118335925> ?p ?o ?g. }

• W3118335925 endingPage "S277" @default.
• W3118335925 startingPage "S276" @default.
• W3118335925 abstract "Abstract Background The Abbott Laboratories SARS-CoV-2 IgG assay and the DiaSorin LIASON SARS-CoV-2 S1/S2 IgG assay are both chemiluminescent immunoassays that qualitatively detect IgG antibodies against SARS-CoV-2 antigens. The Abbott assay detects IgG against the viral nucleocapsid (N) protein, while the DiaSorin assay uses antigen derived from the viral spike (S) protein. Here we evaluate the performance of these two assays at our institution. Methods 45 patient samples (serum or plasma) were tested for anti-SARS-CoV-2 IgG by both the Abbott and DiaSorin assays. The samples were previously characterized at a national reference laboratory using the Abbott assay or by an in-house PCR-based test for SARS-CoV-2 RNA. Samples yielding discordant results across platforms were further tested using the EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG) assay at the reference laboratory. Results 22 samples tested negative for SARS-CoV-2 by the reference lab Abbott assay, and 23 tested positive by the same reference lab test (n = 13) or by an in-house PCR-based test (n = 10). The 22 samples characterized as negative again tested negative by both the Abbott (in-house) and DiaSorin assays (100% NPA). Among the 23 samples characterized as positive, all 23 tested positive by the Abbott assay (100% PPA), while only 15 tested positive by the DiaSorin assay (65% PPA). For each of the 8 discordant cases, samples were further tested by EUROIMMUN assay, which targets the S protein; 7 of the 8 samples tested negative by this assay, in agreement with the DiaSorin test results. Thus, for the discordant cases, testing for IgG against N (in-house and reference lab Abbott assays) gave positive results, while testing for IgG against S (DiaSorin and EUROIMMUN assays) mostly gave negative results. Conclusion These findings highlight the importance of the differences between various SARS-CoV-2 antibody tests, and providers should be aware of the specific antigenic target(s) in each test. Selection of a specific assay may depend on the need to assess past exposure to SARS-CoV-2 (for which a nucleocapsid target may be more sensitive) or to detect neutralizing antibodies (for which a spike target may be more relevant). This also has implications for disease surveillance as reliance on anti-spike antibodies alone may underestimate infection prevalence. Disclosures All Authors: No reported disclosures" @default.
• W3118335925 created "2021-01-18" @default.
• W3118335925 creator A5037942996 @default.
• W3118335925 creator A5087130206 @default.
• W3118335925 date "2020-10-01" @default.
• W3118335925 modified "2023-09-27" @default.
• W3118335925 title "418. Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays" @default.
• W3118335925 doi "https://doi.org/10.1093/ofid/ofaa439.612" @default.
• W3118335925 hasPublicationYear "2020" @default.
• W3118335925 type Work @default.
• W3118335925 sameAs 3118335925 @default.
• W3118335925 citedByCount "0" @default.
• W3118335925 crossrefType "journal-article" @default.
• W3118335925 hasAuthorship W3118335925A5037942996 @default.
• W3118335925 hasAuthorship W3118335925A5087130206 @default.
• W3118335925 hasBestOaLocation W31183359251 @default.
• W3118335925 hasConcept C126322002 @default.
• W3118335925 hasConcept C159047783 @default.
• W3118335925 hasConcept C159654299 @default.
• W3118335925 hasConcept C203014093 @default.
• W3118335925 hasConcept C2779134260 @default.
• W3118335925 hasConcept C3007834351 @default.
• W3118335925 hasConcept C3008058167 @default.
• W3118335925 hasConcept C524204448 @default.
• W3118335925 hasConcept C71924100 @default.
• W3118335925 hasConceptScore W3118335925C126322002 @default.
• W3118335925 hasConceptScore W3118335925C159047783 @default.
• W3118335925 hasConceptScore W3118335925C159654299 @default.
• W3118335925 hasConceptScore W3118335925C203014093 @default.
• W3118335925 hasConceptScore W3118335925C2779134260 @default.
• W3118335925 hasConceptScore W3118335925C3007834351 @default.
• W3118335925 hasConceptScore W3118335925C3008058167 @default.
• W3118335925 hasConceptScore W3118335925C524204448 @default.
• W3118335925 hasConceptScore W3118335925C71924100 @default.
• W3118335925 hasIssue "Supplement_1" @default.
• W3118335925 hasLocation W31183359251 @default.
• W3118335925 hasLocation W31183359252 @default.
• W3118335925 hasLocation W31183359253 @default.
• W3118335925 hasOpenAccess W3118335925 @default.
• W3118335925 hasPrimaryLocation W31183359251 @default.
• W3118335925 hasRelatedWork W3036305013 @default.
• W3118335925 hasRelatedWork W3127693599 @default.
• W3118335925 hasRelatedWork W3176864053 @default.
• W3118335925 hasRelatedWork W3198183218 @default.
• W3118335925 hasRelatedWork W4205317059 @default.
• W3118335925 hasRelatedWork W4205810683 @default.
• W3118335925 hasRelatedWork W4206669628 @default.
• W3118335925 hasRelatedWork W4210401150 @default.
• W3118335925 hasRelatedWork W4224279380 @default.
• W3118335925 hasRelatedWork W4385264226 @default.
• W3118335925 hasVolume "7" @default.
• W3118335925 isParatext "false" @default.
• W3118335925 isRetracted "false" @default.
• W3118335925 magId "3118335925" @default.
• W3118335925 workType "article" @default.